ArticleTheranostics2019

miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.

Lina Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.